|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2004-8-27
|
|
pubmed:abstractText |
Amplification and/or overexpression of HER-2/neu are associated with poor clinical outcome in several epithelial tumors. However, the exact prognostic role of HER-2/neu expression in testicular germ-cell tumors is equivocal.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0250-7005
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
24
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2219-24
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:15330164-Adult,
pubmed-meshheading:15330164-Choriocarcinoma,
pubmed-meshheading:15330164-Humans,
pubmed-meshheading:15330164-Immunohistochemistry,
pubmed-meshheading:15330164-In Situ Hybridization, Fluorescence,
pubmed-meshheading:15330164-Male,
pubmed-meshheading:15330164-Neoplasm Staging,
pubmed-meshheading:15330164-Receptor, erbB-2,
pubmed-meshheading:15330164-Teratoma,
pubmed-meshheading:15330164-Testicular Neoplasms
|
|
pubmed:articleTitle |
Clinical relevance of HER-2/neu expression in germ-cell testicular tumors.
|
|
pubmed:affiliation |
Department of Cytopathology, National Institute of Oncology, Budapest, Hungary.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
